The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2019 | The future prospects of adapting genomics to clinical practice
Wee Joo Chng
• 15 Sep 2019
Prof. Wee Joo Chng, PhD, of the Yong Loo Lin School of Medicine, National University of Singapore, Singapore describes how genomic technologies can predict patient response to treatment, and how advances in understanding will change the approach to clinical practice. This was interview was recorded at the International Myeloma Workshop (IMW) 2019, in Boston, MA.
